On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
FridayDec 03, 2021 1:02 pm

QualityStocksNewsBreaks – Avricore Health Inc. (TSX.V: AVCR) (OTCQB: AVCRF) on Course to Making Actionable Health Information More Accessible

Avricore Health (TSX.V: AVCR) (OTCQB: AVCRF) is increasing access to the innovations of its walk-in pharmacy diagnostic technology. Recently, the company expanded from key cities in Canada’s eastern locales to sites on the western seaboard, where it hopes to diversify the profile of patients using its service. “The addition of five British Columbia outlets through Avricore’s pilot partnership with nationwide pharmaceutical chain Shoppers Drug Mart is expected to serve as an early booster stage for the company’s plans to serve 600 locations by the end of 2023,” reads a recent article. In an earlier news release, CEO Hector Bremner commented:…

Continue Reading

FridayDec 03, 2021 12:30 pm

QualityStocksNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Announces Beginning of Validation Process for Class 2 EV Cargo Vans

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, has started the initial validation testing of its exclusive Class 2 EV cargo van. The testing is taking place at Mullen’s Advanced Manufacturing and Engineering Center (“AMEC”), which is located in Tunica, Mississippi. Based on a 144-inch wheelbase, Mullen’s Class 2 EV cargo van features a 78.8-kWh battery pack as well as rear-wheel drive and a  modular 460-cubic-foot cargo area. In addition, the vehicle offers a range of more than 200 miles and a maximum payload of 3,296 pounds. The innovative cargo van will be exhibited at the January Consumer…

Continue Reading

FridayDec 03, 2021 12:28 pm

Q1 Diagnostic Coverage & Reimbursement Conference, Boston

Date: December 6-7, 2021 Venue: Boston, MA Reimbursement executives attempt to comply with stringent commercial and public payer standards as the diagnostic industry evolves and expands into ever more specialized areas of testing. Provisions and specific evidence required to ensure coverage are always evolving, but the technology appears to be progressing even faster, posing unique hurdles in showing product value and integrating innovative diagnostics into existing payment schemes. The Diagnostic Coverage & Reimbursement conference has brought together more than 1200 industry professionals over the last ten years to discuss crucial challenges affecting diagnostic technology pricing, allowing the industry to better…

Continue Reading

FridayDec 03, 2021 12:18 pm

QualityStocksNewsBreaks – Sugarmade Inc. (SGMD) Expanding End-Market Access in Growing California Cannabis Delivery Sector

Sugarmade (OTC: SGMD), an innovator in the dynamic California cannabis sector, is focused on expanding its end-market access as a central player in the growing space. This comes as more consumers around the world become aware of the potential benefits of cannabis. As a result, the market is projected to see significant growth, with a new Quince Market Insights report estimating that the global cannabis market will grow at a CAGR of 27.0% from 2021 to 2030 (https://ibn.fm/3WgpH) (https://nnw.fm/ESCca) (https://cnw.fm/pZlDm). “The growth factors identified in the market are the proven medicinal effects and legalization of cannabis, developments in intellectual property…

Continue Reading

FridayDec 03, 2021 11:43 am

QualityStocksNewsBreaks – Mind Cure Health Inc. (CSE: MCUR) (OTCQX: MCURF) (FRA: 6MH), Announces Participation in December 2021 Conferences

Mind Cure Health (CSE: MCUR) (OTCQX: MCURF) (FRA: 6MH), a leader in advanced proprietary technology and research for psychedelics, will be featured in several upcoming conferences. The company announced that president and CEO Kelsey Ramsden has been invited to present in four virtual conferences scheduled in December. Those conferences include the H.C. Wainwright's second annual Psychedelics Conference, the Psychedelics Now Virtual Conference, the #CanndoraConnect: Women in Psychedelics Conference, and the Life Sciences Investor Forum. The H.C. Wainwright Psychedelics Conference is scheduled for Dec. 6, 2021; Ramsden’s presentation will begin at 7 a.m. The Psychedelics Now Virtual Conference will be held…

Continue Reading

FridayDec 03, 2021 11:27 am

QualityStocksNewsBreaks – Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) to Present at 2nd Annual H.C. Wainwright Psychedelics Conference

Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF), a pharmaceutical company focused on developing psilocybin-based compounds for diseases with unmet medical needs, today announced that it will present at the Second Annual H.C. Wainwright Psychedelics Conference. The event is slated to be held virtually on Dec. 6, 2021. Tryp’s chairman and CEO Greg McKee will provide an overview of the business and its pipeline, including the upcoming phase 2a clinical trials in fibromyalgia, phantom limb pain, binge eating disorder and other indications. McKee's presentation will be available on-demand through the H.C. Wainwright conference portal beginning at 7:00 a.m. ET. on Monday, Dec.…

Continue Reading

FridayDec 03, 2021 9:37 am

QualityStocksNewsBreaks – SRAX Inc. (NASDAQ: SRAX) Announces Upcoming Sequire Clean Tech & EV Virtual Conference

SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its SaaS (“SaaS”) platform, will be hosting the first-ever Sequire Clean Tech & EV Conference. The investor event will be held on Dec. 6, 2021. This premier gathering is designed to feature a variety of companies, including those in the EV, energy and power, materials and chemicals, and food and agriculture industries. Green energy and sustainability are becoming top priorities in today’s world, and this inaugural gathering is designed to create an invaluable opportunity for premier innovators in the clean-tech space to…

Continue Reading

FridayDec 03, 2021 9:30 am

Mind Cure Health Inc. (CSE: MCUR) (OTCQX: MCURF) (FRA: 6MH) Announces Research and Technology Progress, Offers Corporate Update

Investment banking firm The Maxim Group reiterates ‘buy’ rating on MCURF following the company’s updates on pivotal research and technology, including The Desire Project, manufacturing of synthetic ibogaine, and the iSTRYM platform MINDCURE is focused on developing psychedelic compounds to scale science-backed and evidentiary-based mental health therapy worldwide In July, MINDCURE filed for patents on two routes of full chemical synthesis, which initiated the production of Good Laboratory Practice (“GLP”) ibogaine, which will lead to the production of Good Manufacturing Practice (“GMP”) ibogaine to scale and manufacture a global supply of its synthetic ibogaine In addition to this pre-clinical trial,…

Continue Reading

FridayDec 03, 2021 9:30 am

NCIA’s 7th Annual Cannabis Business Summit & Expo Launches BLOOM: A Brands Experience

The NCIA will host the 7th Annual Cannabis Business Summit & Expo on December 15-17, 2021, in San Francisco This year’s event will feature BLOOM: A Brands Experience, designed to provide attendees with the ability to see, touch, and smell a variety of cannabis products on the expo floor In addition to Bloom, the conference will also feature two unique offsite tours, including a visit to the Dark Heart Nursery, as well as a unique cannabis-infused San Francisco city cruise NCIA’s 7th Annual Cannabis Business Summit & Expo takes place at San Francisco’s Moscone Center from December 15-17, 2021. Hosted…

Continue Reading

FridayDec 03, 2021 9:30 am

FingerMotion Inc. (FNGR) Reports on November 22 Annual Meeting Results

FingerMotion released results from the annual meeting held on November 22, 2021 It announced the re-appointment of executive officers and its Board of Directors It also reported on the appointment of an independent accounting firm FingerMotion (OTCQX: FNGR) held its annual meeting of stockholders on November 22, 2021. Among the issues covered included the election of specific figures into the company’s Board of Directors, coupled with the approval of the FNGR 2021 stock incentive plan and executive compensation. The company just announced that various matters were duly ratified and have since been implemented by its Board. They included: The election…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.


Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered